Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00081744 |
Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.
Condition | Intervention | Phase |
---|---|---|
Gram-Positive Bacterial Infections Cross Infection |
Drug: Tigecycline |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Safety/Efficacy Study |
Official Title: | A Multicenter, Double-Blind, Randomized Comparison Study Of the Efficacy and Safety of Tigecycline to Imipenem/ Cilastatin to Treat Complicated Intra-Abdominal Infections in Hospitalized Subjects |
Ages Eligible for Study: | 8 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 3074A1-301 |
Study First Received: | April 19, 2004 |
Last Updated: | May 17, 2006 |
ClinicalTrials.gov Identifier: | NCT00081744 |
Health Authority: | United States: Food and Drug Administration |
Bacterial Infections |
Bacterial Infections Gram-Positive Bacterial Infections Tigecycline |
Cilastatin Cross Infection Imipenem |
Anti-Infective Agents Anti-Bacterial Agents Communicable Diseases |
Therapeutic Uses Infection Pharmacologic Actions |